Rare Wolf Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Rare Wolf Capital's VRTX Position: Q1 2026 in Review
Rare Wolf Capital increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q1 2026, buying an estimated $191K and bringing the position to 2,425 shares worth $1.08M. The position accounts for 0.7% of the portfolio, ranked #37.
Rare Wolf Capital first reported a position in VRTX in Q4 2025 and has held it in 2 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Rare Wolf Capital held 2,425 shares of Vertex Pharmaceuticals worth $1.08M as of Q1 2026.
- Rare Wolf Capital bought 410 Vertex Pharmaceuticals shares in Q1 2026, an estimated $191K.
- Vertex Pharmaceuticals made up 0.7% of Rare Wolf Capital's portfolio in Q1 2026, its #37 holding.
- Rare Wolf Capital first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Rare Wolf Capital's 13F filing for Q1 2026, filed 14 May 2026.